$0.9759
-0.10-9.64%
Last update: Nov 5, 6:55 PM
Allarity Therapeutics Inc
ALLRNASDAQ
The average analyst price target for Allarity Therapeutics is $11, 1043.5% above the current price. The one analyst covering it rates it Buy. The latest change came on Sep 16, 2026, when Ascendiant Capital raised its price target on Allarity Therapeutics from $10.25 to $11 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 1 Analysts
Rating Trend — Last 9 Months
